Table 3.

Summary of the studies that evaluated radiomics in the hepatocellular carcinoma.

References	Purposes	Type	Treatment	Imaging modality	Feature selection model	Main results
Ji et al. (24)	RFS	Early Stage HCC	Hepatectomy	Contrast-enhanced CT	LASSO	AUC 0.82
Shan et al. (25)	Predict early recurrence	HCC	Hepatectomy	Contrast-enhanced CT	LASSO	AUC 0.80
Zheng et al. (26)	Predict recur-rence and survival	Solitary HCC	Hepatectomy	Contrast-enhanced CT	LASSO	Recurrence AUC 0.64 Survival AUC 0.71
Peng et al. (27)	Prediction of MVI	HBV-related HCC	–	Contrast-enhanced CT	LASSO	c-index 0.846
In this study	Predict survival	HCC with PVTT	SBRT	Contrast-enhanced CT	LASSO	Survival AUC 0.859

RFS, recurrence-free survival; HCC, hepatocellular carcinoma; LASSO, least absolute shrinkage and selection operator; MVI, microvascular invasion; HBV, hepatitis B virus; SBRT, stereotactic body radiotherapy.